Potential use of coronary artery calcium progression to guide the management of patients at risk for coronary artery disease events

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 1, 2012, Pages 69-80

  McEvoy, John W ^a   Blaha, Michael J ^a   Nasir, Khurram ^a   Blumenthal, Roger S ^a   Jones, Steven R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cardiac CT; Coronary Artery Calcium; Primary Prevention; Progression

Indexed keywords

ALPHA TOCOPHEROL; AMIODARONE; ASCORBIC ACID; ATORVASTATIN; CALCIUM ACETATE; CALCIUM BASED PHOSPHATE BINDER; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIFEDIPINE; PHOSPHATE BINDING AGENT; PLACEBO; PRAVASTATIN; SEVELAMER; UNCLASSIFIED DRUG;

ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM TESTING; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE COMPARISON; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MATHEMATICAL MODEL; PRACTICE GUIDELINE; REPEAT PROCEDURE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SUBCLINICAL CORONARY ARTERY DISEASE;

EID: 84857629099     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-011-0154-5     Document Type: Article

References (47)

1. VL Roger AS Go DM Lloyd-Jones, et al. 2011 Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 e18 e209 21160056 10.1161/CIR.0b013e3182009701
2. PK Shah 2010 Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 56 98 105 20620724 10.1016/j.jacc.2009.09.081 The article makes a persuasive argument for subclinical atherosclerosis imaging.
3. L Wexler B Brundage J Crouse, et al. 1996 Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group Circulation 94 1175 1192 8790070 1:STN:280:DyaK28zot1ajtA%3D%3D (Pubitemid 26292883)
4. GS Mintz AD Pichard JJ Popma, et al. 1997 Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study J Am Coll Cardiol 29 268 274 9014977 10.1016/S0735-1097(96)00479-2 1:STN:280:DyaK2s7mslarug%3D%3D (Pubitemid 27059954)
5. R Erbel S Mohlenkamp S Moebus, et al. 2010 Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study J Am Coll Cardiol 56 1397 1406 20946997 10.1016/j.jacc.2010.06.030
6. TS Polonsky RL McClelland NW Jorgensen, et al. 2010 Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 1610 1616 20424251 10.1001/jama.2010.461 1:CAS:528:DC%2BC3cXlsV2mt7g%3D This is the first major analysis of the benefits of a CAC score-based reclassification.
7. A Rozanski H Gransar LJ Shaw, et al. 2011 Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial J Am Coll Cardiol 57 1622 1632 21439754 10.1016/j.jacc.2011.01.019 1:CAS:528:DC%2BC3MXmsVClu7c%3D This is the first randomized study demonstrating the utility of CAC in clinical practice. It is hoped that this will be backed up with outcomes data.
8. P Greenland JS Alpert GA Beller, et al. 2010 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 122 2748 2764 21098427 10.1161/CIR.0b013e3182051bab
9. SE Nissen SJ Nicholls I Sipahi, et al. 2006 Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 1556 1565 16533939 10.1001/jama.295.13.jpc60002 1:CAS:528: DC%2BD28Xjt12itrc%3D
10. JW McEvoy MJ Blaha AP Defilippis, et al. 2010 Coronary artery calcium progression: an important clinical measurement? A review of published reports J Am Coll Cardiol 56 1613 1622 21050970 10.1016/j.jacc.2010.06.038 This is a more detailed discussion of the field of CAC progression.
11. P Greenland JS Alpert GA Beller, et al. 2010 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 122 e584 e636 21098428 10.1161/CIR. 0b013e3182051b4c
12. JW McEvoy 2010 Coronary artery calcium score and cardiovascular event prediction JAMA 304 741 742 20716732 10.1001/jama.2010.1143 1:CAS:528: DC%2BC3cXhtVCqtrjM
13. SE Elias-Smale RV Proenca MT Koller, et al. 2010 Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study J Am Coll Cardiol 56 1407 1414 20946998 10.1016/j.jacc.2010.06. 029
14. M Blaha MJ Budoff LJ Shaw, et al. 2009 Absence of coronary artery calcification and all-cause mortality JACC Cardiovasc Imaging 2 692 700 19520338 10.1016/j.jcmg.2009.03.009
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
16. HS Hecht 2008 The deadly double standard (the saga of screening for subclinical atherosclerosis) Am J Cardiol 101 1805 1807 18549864 10.1016/j.amjcard.2008.02.086
17. MS Ambrose CD Nagy RS Blumenthal 2008 Selective use of coronary calcification measurements in an expanded intermediate risk group J Cardiovasc Comput Tomogr 2 209 213 19083951 10.1016/j.jcct.2008.05.143
18. HC Yoon AM Emerick JA Hill DW Gjertson JG Goldin 2002 Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects Radiology 224 236 241 12091689 10.1148/radiol.2241011191 (Pubitemid 34680400)
19. JK Min FY Lin DS Gidseg, et al. 2010 Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? J Am Coll Cardiol 55 1110 1117 20223365 10.1016/j.jacc.2009.08.088 This article demonstrates that those with zero baseline CAC rarely convert to a positive score before 4 years.
20. DM Lloyd-Jones EP Leip MG Larson, et al. 2006 Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 791 798 16461820 10.1161/CIRCULATIONAHA.105.548206
21. GS Berenson SR Srinivasan W Bao WP Newman 3rd RE Tracy WA Wattigney 1998 Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 338 1650 6 9614255 10.1056/NEJM199806043382302 1:STN:280:DyaK1c3msVCmsg%3D%3D (Pubitemid 28267909)
22. A Tirosh I Shai A Afek, et al. 2011 Adolescent BMI trajectory and risk of diabetes versus coronary disease N Engl J Med 364 1315 1325 21470009 10.1056/NEJMoa1006992 1:CAS:528:DC%2BC3MXkvVCms70%3D
23. SS Gidding 2010 Assembling evidence to justify prevention of atherosclerosis beginning in youth Circulation 122 2493 2494 21126975 10.1161/CIRCULATIONAHA.110.992123
24. A Gopal K Nasir ST Liu FR Flores L Chen MJ Budoff 2007 Coronary calcium progression rates with a zero initial score by electron beam tomography Int J Cardiol 117 227 231 16875746 10.1016/j.ijcard.2006.04.081 (Pubitemid 46454414)
25. JE Hokanson T MacKenzie G Kinney, et al. 2004 Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability AJR Am J Roentgenol 182 1327 1332 15100140 (Pubitemid 38525535)
26. RA Kronmal RL McClelland R Detrano, et al. 2007 Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation 115 2722 2730 17502571 10.1161/CIRCULATIONAHA.106.674143 (Pubitemid 46842788)
27. MJ Budoff JE Hokanson K Nasir, et al. 2010 Progression of coronary artery calcium predicts all-cause mortality JACC Cardiovasc Imaging 3 1229 36 21163451 10.1016/j.jcmg.2010.08.018 This is one of the first studies to compare the prognostic value of different methods of measuring CAC progression.
28. P Raggi TQ Callister LJ Shaw 2004 Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy Arterioscler Thromb Vasc Biol 24 1272 1277 15059806 10.1161/01.ATV.0000127024.40516.ef 1:CAS:528:DC%2BD2cXlt1Wltbk%3D (Pubitemid 38880020)
29. AS Agatston WR Janowitz FJ Hildner NR Zusmer M Viamonte Jr R Detrano 1990 Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 827 832 2407762 10.1016/0735-1097(90)90282-T 1:STN:280:DyaK3c7ntFelug%3D%3D (Pubitemid 20101575)
30. TQ Callister B Cooil SP Raya NJ Lippolis DJ Russo P Raggi 1998 Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method Radiology 208 807 814 9722864 1:STN:280:DyaK1czptVSrug%3D%3D (Pubitemid 28405121)
31. C Hong KT Bae TK Pilgram 2003 Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT-assessment of effects of different thresholds and quantification methods Radiology 227 795 801 12728184 10.1148/radiol.2273020369 (Pubitemid 36583039)
32. SS Mao RS Pal CR McKay, et al. 2009 Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner J Comput Assist Tomogr 33 175 178 19346841 10.1097/RCT.0b013e31817579ee
33. Ghadri JR, Goetti R, Fiechter M, et al. Inter-scan variability of coronary artery calcium scoring assessed on 64-multidetector computed tomography vs. dual-source computed tomography: a head-to-head comparison. Eur Heart J 2011.
34. DL DeMets RM Califf 2002 Lessons learned from recent cardiovascular clinical trials: Part I Circulation 106 746 751 12163438 10.1161/01.CIR. 0000023219.51483.66 (Pubitemid 34851937)
35. TQ Callister P Raggi B Cooil NJ Lippolis DJ Russo 1998 Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography N Engl J Med 339 1972 1978 9869668 10.1056/ NEJM199812313392703 1:CAS:528:DyaK1MXltlaksQ%3D%3D (Pubitemid 29024129)
36. MJ Budoff KL Lane H Bakhsheshi, et al. 2000 Rates of progression of coronary calcium by electron beam tomography Am J Cardiol 86 8 11 10867084 10.1016/S0002-9149(00)00820-1 1:CAS:528:DC%2BD3cXktFSisrY%3D (Pubitemid 30365135)
37. S Achenbach D Ropers K Pohle, et al. 2002 Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation Circulation 106 1077 1082 12196332 10.1161/01.CIR.0000027567.49283.FF 1:CAS:528:DC%2BD38XntVKlu7k%3D (Pubitemid 34970847)
38. ES Houslay SJ Cowell RJ Prescott, et al. 2006 Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial Heart 92 1207 1212 16449511 10.1136/hrt.2005.080929 1:CAS:528:DC%2BD28XpvFOlsL4%3D (Pubitemid 44298857)
39. A Schmermund S Achenbach T Budde, et al. 2006 Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial Circulation 113 427 437 16415377 10.1161/CIRCULATIONAHA.105. 568147 1:CAS:528:DC%2BD28XltVWmsQ%3D%3D (Pubitemid 43803205)
40. P Raggi M Davidson TQ Callister, et al. 2005 Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) Circulation 112 563 571 16009795 10.1161/CIRCULATIONAHA.104.512681 1:CAS:528:DC%2BD2MXmt1yht78%3D (Pubitemid 41060797)
41. Y Arad LA Spadaro M Roth D Newstein AD Guerci 2005 Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial J Am Coll Cardiol 46 166 172 15992652 10.1016/j.jacc.2005.02.089 1:CAS:528:DC%2BD2MXlvVenurs%3D (Pubitemid 40905146)
42. C Burgstahler A Reimann T Beck, et al. 2007 Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study Invest Radiol 42 189 195 17287649 10.1097/01.rli.0000254408.96355.85 1:CAS:528:DC%2BD2sXhsVShsrw%3D (Pubitemid 46232824)
43. M Motro J Shemesh 2001 Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics Hypertension 37 1410 1413 11408386 1:CAS:528:DC%2BD3MXksFOlsLk%3D (Pubitemid 34225383)
44. WG Goodman J Goldin BD Kuizon, et al. 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478 1483 10816185 10.1056/NEJM200005183422003 1:STN:280: DC%2BD3c3ls1OjtA%3D%3D (Pubitemid 30318271)
45. GM Chertow SK Burke P Raggi 2002 Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 245 252 12081584 10.1046/j.1523-1755.2002.00434.x 1:CAS:528:DC%2BD38XlsFyqu74%3D (Pubitemid 34754068)
46. W Qunibi M Moustafa LR Muenz, et al. 2008 A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study Am J Kidney Dis 51 952 965 18423809 10.1053/j.ajkd.2008.02.298 1:CAS:528:DC%2BD1cXotV2hsbY%3D (Pubitemid 351697566)
47. Y Arad KJ Goodman M Roth D Newstein AD Guerci 2005 Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 158 165 15992651 10.1016/j.jacc.2005.02.088 1:CAS:528: DC%2BD2MXlvVenuro%3D (Pubitemid 40905145)